Luis Isola - Concepedia

Author

Luis Isola

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Asad Bashey, Isola, Luis, Jiang, Chen, Johnson, Jeffrey, K Banoff, L Isola, L M Isola, L. ISOLA, L. Isola, L. M. Isola

196

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Mount Sinai Medical Center Medical College of Wisconsin Dana-Farber Cancer Institute Memorial Sloan Kettering Cancer Center

About

Luis Isola is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, hematology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	2.3K
2	Health Sciences	11	11	1.1K
3	Engineering	1	1	20
4	Natural Sciences	1	1	49
5	Nursing	1	1	37

Luis Isola

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister, New England Journal of Medicine	2012	1.1K
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis Mary Eapen, Vanderson Rocha, Guillermo Sanz, The Lancet Oncology Acute LeukaemiaTransplantationMarrow TransplantationGraft SourceImmunology	2010	584
Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome Brian McClune, Daniel J. Weisdorf, Tanya L. Pedersen, Journal of Clinical Oncology Hematological MalignancyFirst Complete RemissionChronic GvhdTransplantationMarrow Transplantation	2010	477
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease Partow Kebriaei, Luis Isola, Erkut Bahceci, Biology of Blood and Marrow Transplantation	2009	431
Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies Robert J. Soiffer, Jennifer Le‐Rademacher, Vincent T. Ho, Blood	2011	350
Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors Theresa Hahn, Philip L. McCarthy, Anna Hassebroek, Journal of Clinical Oncology	2013	243
Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen–Identical Sibling Transplants for Adults With Leukemia Theresa Hahn, Philip L. McCarthy, Mei-Jie Zhang, Journal of Clinical Oncology	2008	203
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia Andromachi Scaradavou, Claudio G. Brunstein, Mary Eapen, Blood	2012	192
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial Sarah A. Holstein, Sin‐Ho Jung, Paul G. Richardson, The Lancet Haematology Hematological MalignancyOncologyMarrow TransplantationTransplantationStem Cell Transplantation	2017	168
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis Mukta Arora, John P. Klein, Daniel J. Weisdorf, Blood	2011	155

Page 1